Advertisement

Tecovirimat No Aid for Time to Lesion Resolution With Mpox

0

Additionally, interim analysis shows that the antiviral is safe but has no effect on pain among adults with mild-to-moderate clade II mpox

DOJ Alleges CVS Facilitated Unlawful Sales, Violating Federal Opioid Regulations

0
By India Edwards HealthDay Reporter THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Department of Justice (DOJ) has filed a civil complaint against CVS...

Antidepressant Use Tied to Reduced Genital Sensitivity

0

Findings show persistent posttreatment genital hypoesthesia among sexual and gender minority youth with history of antidepressant use

FDA Expands Approval of Vtama to Include Atopic Dermatitis

0

The nonsteroidal topical treatment is approved for patients 2 years and older

FDA Says Shortage of GLP-1 Tirzepatide Is Over

0
By Robin Foster HealthDay Reporter THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration re-issued a decision first made by the...

FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning

0
By India Edwards HealthDay Reporter WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has issued its most serious warning...

Antibiotic Use Not Linked to Incident Dementia, Cognitive Impairment

0

No association seen for increased risks for dementia, cognitive impairment without dementia, accelerated cognitive decline

FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis

0

The monoclonal antibody treatment is for patients ages 12 years and older

RSVpreF Vaccine Effective in Preventing Severe RSV in Older Adults

0

Vaccine effectiveness 91 percent using strict controls in a population of adults aged 60 years or older

USPSTF Recommends Against Vitamin D Supplementation for Fracture, Fall Prevention

0

Vitamin D supplementation, with or without calcium, offers no benefit for preventing falls or fractures in community-dwelling seniors